Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone in adults with Prader-Willi syndrome
NL-OMON27149Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of somatropin in Prader-Willi syndrome (PWS) (2 arms), sponsored by Erasmus MC. Primary endpoint: Change in lean body mass. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
somatropin
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NL-OMON27149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27149.